Department of Cardiovascular Sciences and NIHR Biomedical Research Unit in Cardiovascular Diseases, University of Leicester School of Medicine, Leicester, UK.
J Hypertens. 2012 Jun;30 Suppl:S13-8. doi: 10.1097/HJH.0b013e328353e523.
Arterial aging is associated with a progressive increase in aortic stiffening, which results in a rise in central aortic pressures. Traditionally, blood pressure (BP)-lowering therapy has been directed at brachial rather than central pressures. However, a key contemporary question is whether this strategy is optimal in reducing aortic pressure and aortic stiffness, and whether specific treatment strategies might be preferred to reduce the process of arterial aging. This review examines current evidence that BP-lowering treatments can differentially affect aortic pressure and stiffness parameters relative to brachial BP. There is now unequivocal evidence that different treatment regimens can differentially affect BP in the central aorta relative to brachial BP, and emerging evidence of BP-independent differential drug effects on arterial stiffness. A remaining challenge is to link any potentially favorable changes in aortic pressure and/or stiffness to improvements in morbidity and mortality over and above those expected from conventional BP lowering.
动脉老化与主动脉僵硬度的逐渐增加有关,这会导致中心主动脉压力升高。传统上,降压治疗的目标是降低肱动脉血压,而不是中心动脉压。然而,一个当前的关键问题是,这种策略是否能在降低主动脉压力和僵硬度方面达到最佳效果,以及是否有特定的治疗策略可以优先考虑,以减缓动脉老化进程。本综述考察了目前的证据,即降压治疗可以在降低主动脉压力和僵硬度方面与肱动脉血压产生不同的影响。现在已经有明确的证据表明,不同的治疗方案可以在中心主动脉血压与肱动脉血压之间产生不同的降压效果,并且有新的证据表明,降压药物对动脉僵硬度的影响与血压无关。目前仍然存在的挑战是,将主动脉压力和/或僵硬度的任何潜在有利变化与死亡率和发病率的改善联系起来,这些改善超出了常规降压治疗所预期的效果。